Literature DB >> 26769140

Mismatch repair deficiency as a prognostic factor in mucinous colorectal cancer.

Juliana Andrici1,2, Mahtab Farzin1,3, Loretta Sioson1,2, Adele Clarkson1,3, Nicole Watson1, Christopher W Toon1,2,4, Anthony J Gill1,2,3,5.   

Abstract

There is some uncertainty about pathological grading of mucinous colorectal adenocarcinoma, defined as colorectal cancer demonstrating at least 50% mucinous differentiation. Under the WHO 2000 classification mucinous colorectal cancer was considered high grade. However under the current WHO 2010 classification microsatellite unstable/mismatch repair-deficient (MSI/MMRd) mucinous colorectal cancer is considered low grade, whereas microsatellite stable/mismatch repair proficient (MSS/MMRp) tumours are high grade. However there is little empirical evidence for this approach. We therefore compared the long term survival of patients with MSI/MMRd vs MSS/MMRp mucinous colorectal cancer in a large unselected cohort of patients undergoing surgery at our institution from 1998 to 2011. There were 2608 patients in the cohort, of which 264 (10.1%) were mucinous. 95 (36%) of the mucinous tumours were microsatellite unstable. The all-cause 5-year survival of mucinous MSI/MMRd colorectal cancer was similar to that of non-mucinous low-grade colorectal cancer (73 vs 67%, P=0.368), and significantly better than that of both non-mucinous high-grade (73 vs 53%, P<0.001) and mucinous MSS/MMRp colorectal cancer (73 vs 57%, P=0.023). The 5-year survival of mucinous MSS/MMRp colorectal cancer was slightly better than that of non-mucinous high-grade patients (57 vs 53%, P=0.027), but significantly worse than that of non-mucinous low-grade colorectal cancer (57 vs 67%, P=0.018). In multivariate Cox regression analysis, conventional histological grade based on glandular differentiation maintained prognostic significance (P=0.003) whereas MSI/MMRd status just failed to be statistically significant (P=0.062). Our findings support the WHO 2010 approach that as a group mucinous MSS/MMRp colorectal cancers are biologically aggressive. However, grading based exclusively on MSI/MMR status may be overly simplistic as conventional grading based on the degree of glandular differentiation still holds greater prognostic significance in multivariate analysis.

Entities:  

Mesh:

Year:  2016        PMID: 26769140     DOI: 10.1038/modpathol.2015.159

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  26 in total

1.  BRAF-mutated, microsatellite-stable adenocarcinoma of the proximal colon: an aggressive adenocarcinoma with poor survival, mucinous differentiation, and adverse morphologic features.

Authors:  Reetesh K Pai; Priya Jayachandran; Albert C Koong; Daniel T Chang; Shirley Kwok; Lisa Ma; Daniel A Arber; Raymond R Balise; Raymond R Tubbs; Bonnie Shadrach; Rish K Pai
Journal:  Am J Surg Pathol       Date:  2012-05       Impact factor: 6.394

2.  Should the grading of colorectal adenocarcinoma include microsatellite instability status?

Authors:  Christophe Rosty; Elizabeth J Williamson; Mark Clendenning; Rhiannon J Walters; Aung K Win; Mark A Jenkins; John L Hopper; Ingrid M Winship; Melissa C Southey; Graham G Giles; Dallas R English; Daniel D Buchanan
Journal:  Hum Pathol       Date:  2014-07-17       Impact factor: 3.466

3.  A 10-year outcomes evaluation of mucinous and signet-ring cell carcinoma of the colon and rectum.

Authors:  Hakjung Kang; Jessica B O'Connell; Melinda A Maggard; Jonathan Sack; Clifford Y Ko
Journal:  Dis Colon Rectum       Date:  2005-06       Impact factor: 4.585

4.  BRAFV600E immunohistochemistry facilitates universal screening of colorectal cancers for Lynch syndrome.

Authors:  Christopher W Toon; Michael D Walsh; Angela Chou; David Capper; Adele Clarkson; Loretta Sioson; Stephen Clarke; Scott Mead; Rhiannon J Walters; Mark Clendenning; Christophe Rosty; Joanne P Young; Aung Ko Win; John L Hopper; Ashley Crook; Andreas von Deimling; Mark A Jenkins; Daniel D Buchanan; Anthony J Gill
Journal:  Am J Surg Pathol       Date:  2013-10       Impact factor: 6.394

5.  Clinicopathological characteristics of mucinous carcinoma of the colon and rectum.

Authors:  T Nozoe; H Anai; S Nasu; K Sugimachi
Journal:  J Surg Oncol       Date:  2000-10       Impact factor: 3.454

6.  Prognostic significance of microsatellite instability in sporadic mucinous colorectal cancers.

Authors:  L Messerini; M Ciantelli; S Baglioni; A Palomba; G Zampi; L Papi
Journal:  Hum Pathol       Date:  1999-06       Impact factor: 3.466

Review 7.  Mucinous subtype as prognostic factor in colorectal cancer: a systematic review and meta-analysis.

Authors:  J Verhulst; L Ferdinande; P Demetter; W Ceelen
Journal:  J Clin Pathol       Date:  2012-01-18       Impact factor: 3.411

8.  Survival of patients diagnosed with either colorectal mucinous or non-mucinous adenocarcinoma: a population-based study in Canada.

Authors:  Lin Xie; Paul J Villeneuve; Amanda Shaw
Journal:  Int J Oncol       Date:  2009-04       Impact factor: 5.650

9.  A further investigation of combined mismatch repair and BRAFV600E mutation specific immunohistochemistry as a predictor of overall survival in colorectal carcinoma.

Authors:  Nathan Luey; Christopher W Toon; Loretta Sioson; Adele Clarkson; Nicole Watson; Carmen Cussigh; Andrew Kedziora; Stuart Pincott; Stephen Pillinger; Justin Evans; John Percy; Alexander Engel; Margaret Schnitzler; Anthony J Gill
Journal:  PLoS One       Date:  2014-08-25       Impact factor: 3.240

10.  Microsatellite instability and BRAF mutation testing in colorectal cancer prognostication.

Authors:  Paul Lochhead; Aya Kuchiba; Yu Imamura; Xiaoyun Liao; Mai Yamauchi; Reiko Nishihara; Zhi Rong Qian; Teppei Morikawa; Jeanne Shen; Jeffrey A Meyerhardt; Charles S Fuchs; Shuji Ogino
Journal:  J Natl Cancer Inst       Date:  2013-07-22       Impact factor: 13.506

View more
  12 in total

1.  Mapping clinicopathological entities within colorectal mucinous adenocarcinomas: a hierarchical clustering approach.

Authors:  Charly Liddell; Laure Droy-Dupré; Sylvie Métairie; Fabrice Airaud; Christelle Volteau; Stéphane Bezieau; Christian L Laboisse; Jean-François Mosnier
Journal:  Mod Pathol       Date:  2017-04-21       Impact factor: 7.842

2.  Associations among histological characteristics and patient outcomes in colorectal carcinoma with a mucinous component.

Authors:  Raul S Gonzalez; Justin M M Cates; Kay Washington
Journal:  Histopathology       Date:  2018-11-11       Impact factor: 5.087

3.  Colorectal carcinomas with mucinous differentiation are associated with high frequent mutation of KRAS or BRAF mutations, irrespective of quantity of mucinous component.

Authors:  Xiaodong Li; Katherine Sun; Xiaoyan Liao; Haijuan Gao; Hongfa Zhu; Ruliang Xu
Journal:  BMC Cancer       Date:  2020-05-08       Impact factor: 4.430

Review 4.  Mucinous colorectal adenocarcinoma: clinical pathology and treatment options.

Authors:  Cong Luo; Shuyi Cen; Guojun Ding; Wei Wu
Journal:  Cancer Commun (Lond)       Date:  2019-03-29

5.  Adenocarcinoma with mixed subtypes is a rare but aggressive histologic subtype in colorectal cancer.

Authors:  Hui Sheng; Xiaoli Wei; Minjie Mao; Jincan He; Tianqi Luo; Shilin Lu; Liye Zhou; Zhixin Huang; Anli Yang
Journal:  BMC Cancer       Date:  2019-11-08       Impact factor: 4.430

6.  Tumour infiltrating lymphocyte status is superior to histological grade, DNA mismatch repair and BRAF mutation for prognosis of colorectal adenocarcinomas with mucinous differentiation.

Authors:  David S Williams; Dmitri Mouradov; Marsali R Newman; Elham Amini; David K Nickless; Catherine G Fang; Michelle Palmieri; Anuratha Sakthianandeswaren; Shan Li; Robyn L Ward; Nicholas J Hawkins; Iain Skinner; Ian Jones; Peter Gibbs; Oliver M Sieber
Journal:  Mod Pathol       Date:  2020-02-11       Impact factor: 7.842

7.  Automated Quantitation of CD8-positive T Cells Predicts Prognosis in Colonic Adenocarcinoma With Mucinous, Signet Ring Cell, or Medullary Differentiation Independent of Mismatch Repair Protein Status.

Authors:  Douglas J Hartman; Madison Frank; Lindsey Seigh; Haroon Choudry; James Pingpank; Matthew Holtzman; David Bartlett; Nathan Bahary; Liron Pantanowitz; Reetesh K Pai
Journal:  Am J Surg Pathol       Date:  2020-07       Impact factor: 6.298

Review 8.  Constitutional mismatch repair-deficiency: current problems and emerging therapeutic strategies.

Authors:  Malak Abedalthagafi
Journal:  Oncotarget       Date:  2018-10-23

9.  Cancer-associated stroma reveals prognostic biomarkers and novel insights into the tumour microenvironment of colorectal cancer and colorectal liver metastases.

Authors:  Kai M Brown; Aiqun Xue; Ross C Smith; Jaswinder S Samra; Anthony J Gill; Thomas J Hugh
Journal:  Cancer Med       Date:  2021-12-07       Impact factor: 4.452

10.  Risk Factors for Recurrence of Radically Resected Mucinous Colorectal Adenocarcinoma.

Authors:  Qing Huang; Min-Hong Zou; Jian-Chang Wei; Ye Jiang; Zhuan-Peng Chen; Qiang Wang; Wang-Lin Li; Jie Cao
Journal:  Cancer Manag Res       Date:  2021-06-17       Impact factor: 3.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.